Vimarsana
Biggest News Aggregation in the World

Page 7 - Forefront Analytics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Forefront Analytics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Forefront Analytics Today - Breaking & Trending Today

JMP Securities Reaffirms "Market Outperform" Rating for Athira Pharma (NASDAQ:ATHA) - Vimarsana News

JMP Securities Reaffirms "Market Outperform" Rating for Athira Pharma (NASDAQ:ATHA)

JMP Securities reiterated their market outperform rating on shares of Athira Pharma (NASDAQ:ATHA – Free Report) in a report issued on Thursday morning, Benzinga reports. The brokerage currently has a $19.00 price target on the stock. Athira Pharma Price Performance Athira Pharma stock opened at $2.52 on Thursday. The stock’s 50 day moving average is […]

Source: wkrb13.com
HC Wainwright Analysts Increase Earnings Estimates for Annexon, Inc. (NASDAQ:ANNX) - Vimarsana News

HC Wainwright Analysts Increase Earnings Estimates for Annexon, Inc. (NASDAQ:ANNX)

Annexon, Inc. (NASDAQ:ANNX – Free Report) – Research analysts at HC Wainwright lifted their Q2 2024 earnings estimates for Annexon in a report issued on Tuesday, May 14th. HC Wainwright analyst A. Fein now expects that the company will post earnings per share of ($0.22) for the quarter, up from their prior forecast of ($0.37). […]

Source: wkrb13.com
Annexon (NASDAQ:ANNX) Given "Buy" Rating at HC Wainwright - Vimarsana News

Annexon (NASDAQ:ANNX) Given "Buy" Rating at HC Wainwright

HC Wainwright restated their buy rating on shares of Annexon (NASDAQ:ANNX – Free Report) in a report issued on Tuesday, Benzinga reports. The firm currently has a $30.00 price target on the stock. HC Wainwright also issued estimates for Annexon’s Q2 2024 earnings at ($0.22) EPS, Q3 2024 earnings at ($0.23) EPS, Q4 2024 earnings […]

Annexon (NASDAQ:ANNX) Earns "Buy" Rating from Needham & Company LLC - Vimarsana News

Annexon (NASDAQ:ANNX) Earns "Buy" Rating from Needham & Company LLC

Needham & Company LLC restated their buy rating on shares of Annexon (NASDAQ:ANNX – Free Report) in a research report report published on Monday morning, Benzinga reports. They currently have a $16.00 target price on the stock. Other equities research analysts also recently issued research reports about the stock. HC Wainwright reissued a buy rating […]

Insider Selling: ALX Oncology Holdings Inc. (NASDAQ:ALXO) Insider Sells 12,000 Shares of Stock - Vimarsana News

Insider Selling: ALX Oncology Holdings Inc. (NASDAQ:ALXO) Insider Sells 12,000 Shares of Stock

ALX Oncology Holdings Inc. (NASDAQ:ALXO – Get Free Report) insider Sophia Randolph sold 12,000 shares of ALX Oncology stock in a transaction that occurred on Monday, May 13th. The shares were sold at an average price of $15.94, for a total transaction of $191,280.00. Following the completion of the transaction, the insider now owns 330,349 […]

Source: wkrb13.com